# FDA Approves Pregabalin Generic from Eskayef Pharmaceuticals Eskayef Pharmaceuticals Limited received FDA approval for its generic pregabalin oral ...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Sobi, Inc. received FDA approval for VONJO (pacritinib) to treat adult patients with Philadelphia-negative myelofibrosis who have intolerant or refrac...
# FDA Approves Generic Divalproex Sodium for BluePoint Laboratories BluePoint Laboratories has received FDA approval for its generic divalproex sodiu...
Amneal Pharmaceuticals announced the FDA approval of its intravenousfilgrastim injection under the brand name RELEUKO, positioning the company to expa...
ScieGen Pharmaceuticals, Inc. secured approval for generic Metformin HCl Extended-Release Tablets, addressing a significant portion of the massive Typ...
INGENUS PHARMS is expected to see a positive impact on its consolidated sales following the receipt of FDA approval for its generic equivalent under A...
# FDA Approves Apotex's Generic Brimonidine Tartrate Ophthalmic Treatment Apotex Corp. received FDA approval for its generic brimonidine tartrate oph...
# FDA Approves Genentech's VABYSMO for Retinal Disease Treatment Genentech has received FDA approval for VABYSMO (faricimab), a novel intravitreal in...
Sandoz Inc. received FDA approval to market the generic version of tafluprost (ANDA 209040) on Jan. 28, 2022, introducing a new low-cost option to the...
# FDA Approval Newswire Mylan received FDA approval for a generic drug application (ANDA210275) on January 26, 2022, positioning the company to captu...
Hikma Pharmaceuticals USA Inc. received FDA approval for a new generic of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate, raising potentia...
On January 25, 2022, Teva Pharmaceuticals received FDA approval for ANDA211272, a move which, while filling a specific regulatory void, does not curre...
# FDA Approves Generic Vigabatrin The FDA has approved Zydus Pharmaceuticals' generic version of vigabatrin, an oral antiepileptic medication, potent...
New York, January 14, 2022 – U.S. Pharmaceuticals announced today the FDA approval of CIBINQO (abrocitinib), a novel oral therapy for chronic urticari...
# FDA Approves Alembic Pharmaceuticals' Doxycycline Hyclate Generic Alembic Pharmaceuticals Limited has received FDA approval for its generic doxycyc...
Cranbury Pharmaceuticals, LLC won FDA approval for its ANDA201295 generic of Hydrocodone Bitartrate and Acetaminophen, marking the company's entry int...
# FDA Approves Novartis's LEQVIO (Inclisiran) for Cholesterol Management The FDA has approved Novartis Pharmaceuticals Corporation's LEQVIO (inclisir...
# FDA Approves New Generic Drug Application for PharmObedient The FDA has approved ANDA 208120 for PharmObedient, expanding the manufacturer's generi...
# FDA Approves New Oral Formulation of Janssen's XARELTO (Rivaroxaban) The U.S. Food and Drug Administration has approved Janssen Pharmaceuticals' XA...
# FDA Approves argenx's VYVGART for Myasthenia Gravis argenx US received FDA approval for VYVGART (efgartigimod alfa), a novel intravenous immunoglob...